Mouse models for hereditary nonpolyposis colorectal cancer

Cancer Research

Volumn 58, Issue 2, 1998, Pages 248-255

  De Wind, Niels ^a   Dekker, Marleen ^a   Van Rossum, Agnes ^a   Van Der Valk, Martin ^a   Te Riele, Hein ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; GENE LOSS; GERM LINE; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CLONE CELLS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ETHYLNITROSOUREA; FEMALE; GENE DELETION; IMMUNOCOMPROMISED HOST; LOSS OF HETEROZYGOSITY; LYMPHOMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUTS HOMOLOG 2 PROTEIN; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE;

EID: 0031984094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lynch, H. T., and Smyrk, T. C. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer (Phila.), 78: 1149-1167, 1996.
2. Lynch, H. T., Smyrk, T., Lynch, R., Fitzgibbons, R., Jr., Lanspa, S., and McGinn, T. Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. Eur. J. Cancer, 31A: 1039-1046, 1995.
3. Aarnio, M., Mecklin, J-P., Aaltonen, L. A., Nyström-Lathi, M., and Järvinen, H. J. Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer, 64: 430-433, 1995.
4. Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell, 75: 1027-1038, 1993.
5. Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., Guan, X-Y., Zhang, L., Meltzer, P. S., Yu, J-W., Kao, F-T., Chen, D. J., Cerosaletti, K. M., Fournier, R. E. K., Todd, S., Lewis, T., Leach, R. J., Naylor, S. L., Weissenbach, J., Mecklin, J-P., Järvinen, H., Petersen, G. M., Hamilton, S. R., Green, J., Jass, J., Watson, P., Lynch, H. T., Trent, J. M., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.
6. + tumor cells. Cell, 75: 1227-1236, 1993.
7. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergård, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjøld, M., Fishel, R., Kolodner, R., and Liskay, R. M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (Lond.), 368: 258-261, 1994.
8. Kolodner, R. D., Hall, N. R., Lipford, J., Kane, M. F., Rao, M. R. S., Morrison, P., Wirth, L., Finan, P. J., Burn, J., Chapman, P., Earabino, C., Merchant, E., and Bishop, D. T. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics, 24: 516-526, 1994.
9. Kolodner, R. D., Hall, N. R., Lipford, J., Kane, M. F., Morrison, P., Wirth, L., Finan, P. J., Burn, J., Chapman, P., Earabino, C., Merchant, E., and Bishop, D. T. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res., 55: 242-248, 1994.
10. Liu, B., Parsons, R. E., Hamilton, S. R., Petersen, G. M., Lynch, H. T., Watson, P., Markowitz, S., Willson, J. K. V., Green, J., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res., 54: 4590-4594, 1994.
11. Nicolaides, N. C., Papadopoulos, N., Liu, B., Wei, Y-F., Carter, K-C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Dunlop, M. G., Hamilton, S. R., Petersen, G. M., de la Chapelle, A., Vogelstein, B., and Kinzler, K. W. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (Lond.), 371: 75-80, 1994.
12. Papadopoulos, N., Nicolaides, N. C., Wei, Y-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomäki, P., Mecklin, J-P., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutation of a mutL homolog in hereditary colon cancer. Science (Washington DC), 263: 1625-1629, 1994.
13. Hemminki, A., Peltomäki, P., Mecklin, J-P., Jarvinen, H., Salovaara, R., Nyström-Lahti, M., de la Chapelle, A., and Aaltonen, L. A. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat. Genet., 8: 405-410, 1994.
14. Lu, S-L., Akiyama, Y., Nagasaki, H., Nomizu, T., Ikeda, E., Baba, S., Ushio, K., Iwama, T., Maruyama, K., and Yuasa, Y. Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations. Jpn. J. Cancer Res., 87: 279-287, 1996.
15. Ionov, J., Peinado, P. A., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
16. Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkanen, L., Mecklin, J. P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., Petersen, G. M., Kinzler, K. W., Vogelstein, B., and de la Chapelle, A. Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC), 260: 812-816, 1993.
17. Thibodeau, S., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816-819, 1993.
18. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev., 10: 1433-1442, 1996.
19. Modrich, P., and Lahue, R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem., 65: 101-133, 1996.
20. Marsischky, G. T., Filosi, N., Kane, M. F., and Kolodner, R. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev., 10: 407-420, 1996.
21. Drummond, J. T., Li, G-M., Longley, M. J., and Modrich, P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science (Washington DC), 268: 1909-1912, 1995.
22. Palombo, F., Gallinary, P., Iaccarino, I., Lettieri, T., Hughes, M., D'Arrigo, A., Truong, O., Hsuan, J. J., and Jiricny, J. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science (Washington DC), 268: 1912-1914, 1995.
23. Iaccarino, I., Palombo, F., Drummond, J., Totty, N. F., Hsuan, J. J., Modrich, P., and Jiricny, J. MSH6, a Saccharomyces cerevisiae protein that binds to mismatches as a heterodimer with MSH2. Curr. Biol., 6: 484-486, 1996.
24. Li, G. M., and Modrich, P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA, 92: 1950-1954, 1995.
25. Friedberg, E. C., Walker, G. C., and Siede, W. Mismatch repair. In: DNA Repair and Mutagenesis, pp. 367-399. Washington, DC: ASM Press, 1995.
26. Rayssiguier, C., Thaler, D. S., and Radman, M. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature (Lond.), 342: 396-401, 1989.
27. Selva, E. M., New, L., Crouse, G. F., and Lahue, R. S. Mismatch correction acts as a barrier to homeologous recombination in Saccharomyces cerevisiae. Genetics, 139: 1175-1188, 1995.
28. De Wind, N., Dekker, M., Berns, A., Radman, M., and te Riele, H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell, 82: 321-330, 1995.
29. Karran, P., and Bignami, M. DNA damage tolerance, mismatch repair and genome instability. Bioessays, 16: 833-839, 1994.
30. Karran, P., and Hampson, R. Genomic instability and tolerance to alkylating agents. Cancer Surv., 28: 69-85, 1996.
31. Leach, F. S., Polyak, K., Burrell, M., Johnson, K. A., Hill, D., Dunlop, M. G., Wyllie, A. H., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res., 56: 235-240, 1996.
32. Wilson, T. M., Ewel, A., Duguid, J. R., Eble, J. N., Lescoe, M. K., Fishel, R., and Kelley, M. R. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res., 55: 5146-5150, 1995.
33. Varlet, I., Pallard, C., Radman, M., Moreau, J., and de Wind, N. Cloning and expression of the Xenopous and mouse Msh2 DNA mismatch repair genes. Nucleic Acids Res., 22: 5723-5728, 1994.
34. Cohen, P. R., Kohn, S. R., and Kuzrock, R. Association of sebaceous gland tumours and internal malignancy: the Muir-Torre syndrome. Am. J. Med., 90: 606-613, 1991.
35. Branch, P., Bicknell, D. C., Rowan, A., Bodmer, W. F., and Karran, P. Immune surveillance in colorectal carcinoma. Nat. Genet., 9: 231-232, 1995.
36. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Wilson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 26: 1336-1338, 1995.
37. Baker, S. M., Bronner, C. E., Zhang, L., Plug, A. W., Robatzek, M., Warren, G., Elliott, E. A., Yu, J., Ashley, T., Arnheim, N., Flavell, R. A., and Liskay, R. M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell, 82: 309-319, 1995.
38. Reitmair, A. H., Schmits, R., Ewel, A., Bapat, B., Redston, M., Mitri, A., Waterhouse, P., Mittrucker, H. W., Wakeham, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Ballhausen, W. G., Fishel, R., and Mak, T. W. MSH2-deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet., 11: 64-70, 1995.
39. Baker, S. M., Plug, A. W., Prolla, T. A., Bronner, C. E., Harris, A. C., Yao, X., Christie, D. M., Monel, L. C., Arnheim, N., Bradley, A., Ashley, T., and Liskay, R. M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet., 13: 336-342, 1996.
40. Edelmann, W., Cohen, P. E., Kane, M., Lau, K., Morrow, B., Bennett, S., Umar, A., Kunkel, T., Cattoretti, G., Chaganti, R., Pollard, J. W., Kolodner, R. D., and Kucherlapati, R. Meiotic pachytene arrest in MLH1-deficient mice. Cell, 85: 1125-1134, 1996.
41. Reitmair, A. H., Redston, M., Cai, J. C., Chuang, T. C. Y., Bjerknes, M., Cheng, H., Hay, K., Gallinger, S., Bapat, B., and Mak, T. W. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res., 56: 3842-3849, 1996.
42. Van Kaer, L., Ashton-Rickhardt, P. G., Ploegh, H. L., and Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell, 71: 1205-1214, 1992.
43. Su, L-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Washington DC), 256: 668-670, 1992.
44. Dove, W. F., Gould, K. A., Luongo, C., Moser, A. R., and Shoemaker, A. R. Emergent issues in the genetics of intestinal neoplasia. Cancer Surv., 25: 335-354, 1995.
45. Tourne, S., van Santen, H. M., van Roon, M., Berns, A., Benoist, C., Mathis, D., and Ploegh, H. Biosynthesis of major histocompatibility complex molecules and generation of T cells in Li TAP1 double-mutant mice. Proc. Natl. Acad. Sci. USA, 93: 1464-1469, 1996.
46. Gabriel, A., Helman, T., and Wilks, A. A PCR-based assay for the murine multiple intestinal neoplasia (Min) mutation. Mouse Genome, 91: 326-328, 1993.
47. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borensyein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 631-639, 1993.
48. Dietrich, W. F., Miller, J. C., Steen, R. G., Merchant, M., Damron, D., Nahf, R., Gross, A., Joyce, D. C., Wessel, M., Dredge, R. D., Marquis, A., Stein, L. D., Goodman, N., Page, D. C., and Lander, E. C. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat. Genet., 7: 220-240, 1994.
49. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
50. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
51. Neefjes, J. J., Momburg, F., and Hämmerling, G. J. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science (Washington DC), 261: 769-771, 1993.
52. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
53. + in intestinal adenomas from Min mice. Cancer Res., 54: 5947-5952, 1994.
54. Reitmar, A. H., Cai, J-C., Bjerknes, M., Redston, M., Cheng, H., Pind, M. T. L., Hay, K., Mitri, A., Bapat, B. V., Mak, T. W., and Gallinger, S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res., 56: 2922-2926, 1996.
55. Miyashiro, I., Senda, T., Matsumine, A., Baeg, G. H., Kuroda, T., Shimano, T., Miura, S., Noda, T., Kobayashi, S., Monden, M., Toyoshima, K., and Akiyama, T. Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin. Oncogene, 11: 89-96, 1995.
56. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 5: 3075-3079, 1991.
57. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5: 225-229, 1993.
58. Van der Valk, M. A. Survival, tumor incidence and gross pathology in 33 mouse strains. In: J. Hilgers and M. Sluyser (eds.), Mammary Tumors in the Mouse, pp. 46-115. Amsterdam: Elsevier North-Holland Biomedical Press, 1981.
59. Bicknell, D. C., Kaklamanis, L., Hampson, R., Bodmer, W. F., and Karran, P. Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr. Biol., 6: 1695-1697, 1996.
60. Parsons, R., Li, G-M., Longley, M., Modrich, P., Liu, B., Berk, T., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Mismatch repair deficiency in phenotypically normal human cells. Science (Washington DC), 268: 738-740, 1995.
61. min and an activated ras mutation is sufficient to induce colon carcinomas Mol. Cell. Biol., 16: 884-891, 1996.
62. Ponder, B. A. J., and Wilkinson, M. M. Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice. J. Natl. Cancer Inst., 77: 967-976, 1986.
63. Novelli, M. R., Williamson, J. A., Tomlinson, I. P. M., Elia, G., Hodgson, S. V., Talbot, I. C., Bodmer, W. F., and Wright, N. A. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (Washington DC), 272: 1187-1190, 1996.
64. Young, J., Leggett, B., Gustafson, C., Ward, M., Searle, J., Thomas, L., Buttenshaw, R., and Chenevix-Trench, G. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat., 2: 351-354, 1993.